|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
23
|
|
pubmed:dateCreated |
2003-12-9
|
|
pubmed:abstractText |
Pulmonary embolism occurs frequently in hospitalized patients. Thrombolytic therapy, currently used as the major treatment, has often been associated with severe bleeding complications and has thereby been life-threatening. We have developed a novel therapeutic method based on our newly created pulmonary endothelium-specific antibody.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
9
|
|
pubmed:volume |
108
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2892-8
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:14610017-Animals,
pubmed-meshheading:14610017-Antibodies, Monoclonal,
pubmed-meshheading:14610017-Antibody Specificity,
pubmed-meshheading:14610017-Capillaries,
pubmed-meshheading:14610017-Drug Evaluation, Preclinical,
pubmed-meshheading:14610017-Endothelium, Vascular,
pubmed-meshheading:14610017-Female,
pubmed-meshheading:14610017-Fibrinogen,
pubmed-meshheading:14610017-Fibrinolytic Agents,
pubmed-meshheading:14610017-Hemorrhage,
pubmed-meshheading:14610017-Immunoconjugates,
pubmed-meshheading:14610017-Lung,
pubmed-meshheading:14610017-Membrane Proteins,
pubmed-meshheading:14610017-Mice,
pubmed-meshheading:14610017-Mice, Inbred BALB C,
pubmed-meshheading:14610017-Pulmonary Embolism,
pubmed-meshheading:14610017-Rats,
pubmed-meshheading:14610017-Rats, Sprague-Dawley,
pubmed-meshheading:14610017-Specific Pathogen-Free Organisms,
pubmed-meshheading:14610017-Thrombolytic Therapy,
pubmed-meshheading:14610017-Tissue Distribution,
pubmed-meshheading:14610017-Urokinase-Type Plasminogen Activator
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Lung endothelium targeting for pulmonary embolism thrombolysis.
|
|
pubmed:affiliation |
Institute of Molecular Medicine and State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, China.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
